Breast cancer and estrogen replacement therapy

Area of Science:

• Endocrinology
• Oncology
• Epidemiology

Background:

• Estrogen replacement therapy (ERT) is widely used by postmenopausal women.
• Concerns exist regarding ERT's potential link to breast cancer development.

Purpose of the Study:

• To investigate the association between prior estrogen use and breast cancer risk in postmenopausal women.
• To differentiate risks based on menopausal status (natural vs. surgical) and estrogen administration route.

Main Methods:

• A case-control study comparing 199 postmenopausal breast cancer patients with 451 hospital and 852 community control subjects.
• Data collected on prior estrogen use, including route, duration, and dosage.

Main Results:

• Estrogen use showed no increased breast cancer risk in women with surgical menopause.
• Among women with natural menopause, all routes of estrogen administration were associated with a 1.7-1.8 increased risk.
• Injectable estrogens demonstrated a fourfold increase in breast cancer risk for naturally menopausal women.
• Oral estrogen use showed non-significant risk increases (1.3 and 1.2) when injectable use was excluded.

Conclusions:

• The route of estrogen administration is a critical factor in ERT's association with breast cancer risk.
• Injectable estrogens pose a significantly higher risk for breast cancer in naturally menopausal women compared to oral forms.